{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-043417","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2024-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.139106+00:00","generated_at":"2026-06-04T00:24:39.140662+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Corbus enters amended employment agreements with CEO and CFO; base salaries $622,804 and $463,455","bullets":["CEO Yuval Cohen's 2-year agreement: base salary $622,804, bonus target up to 60% of base.","CFO Sean Moran's 2-year agreement: base salary $463,455, bonus target up to 40% of base.","Change-in-control severance: CEO 24 months salary, CFO 18 months; plus accelerated equity vesting.","Non-compete (6 months) and non-solicitation (12 months) apply, conditional on severance.","Agreements expire April 10, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-043417","json":"https://secwatch.observer/filing/0000950170-24-043417.json","markdown":"https://secwatch.observer/filing/0000950170-24-043417.md","text":"https://secwatch.observer/filing/0000950170-24-043417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024043417/0000950170-24-043417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024043417/crbp-20240409.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:24:39.140662+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}